Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPE [AMEX]
Ampio Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.09 Insider Own0.40% Shs Outstand187.20M Perf Week9.55%
Market Cap336.45M Forward P/E- EPS next Y-0.08 Insider Trans-4.86% Shs Float170.94M Perf Month0.58%
Income-15.90M PEG- EPS next Q-0.02 Inst Own14.80% Short Float11.79% Perf Quarter10.97%
Sales- P/S- EPS this Y11.90% Inst Trans30.58% Short Ratio6.87 Perf Half Y108.99%
Book/sh0.09 P/B19.11 EPS next Y11.10% ROA-107.50% Target Price- Perf Year245.17%
Cash/sh0.09 P/C19.45 EPS next 5Y- ROE-173.80% 52W Range0.45 - 2.98 Perf YTD8.18%
Dividend- P/FCF- EPS past 5Y26.60% ROI- 52W High-40.27% Beta1.77
Dividend %- Quick Ratio10.10 Sales past 5Y- Gross Margin- 52W Low292.48% ATR0.14
Employees18 Current Ratio10.10 Sales Q/Q- Oper. Margin- RSI (14)55.37 Volatility9.01% 8.37%
OptionableYes Debt/Eq0.00 EPS Q/Q-271.40% Profit Margin- Rel Volume0.45 Prev Close1.72
ShortableYes LT Debt/Eq0.00 EarningsMar 03 AMC Payout- Avg Volume2.93M Price1.78
Recom2.00 SMA205.73% SMA501.29% SMA20042.08% Volume234,034 Change3.48%
Dec-19-19Initiated ROTH Capital Buy $4
Mar-17-14Reiterated Aegis Capital Buy $15 → $16
Sep-25-12Initiated Aegis Capital Buy $11
Apr-21-21 09:15AM  
Apr-19-21 09:15AM  
Apr-06-21 09:15AM  
Apr-01-21 09:57AM  
Mar-29-21 09:15AM  
Mar-19-21 09:15AM  
Mar-16-21 09:15AM  
Mar-10-21 04:01PM  
Mar-04-21 12:33PM  
01:30AM  
Mar-03-21 04:01PM  
02:30PM  
09:15AM  
Feb-24-21 09:15AM  
Feb-23-21 09:15AM  
Feb-16-21 09:15AM  
Feb-01-21 09:15AM  
Jan-14-21 09:15AM  
Jan-04-21 09:15AM  
Dec-29-20 03:59PM  
09:15AM  
Dec-23-20 03:33PM  
Dec-17-20 09:15AM  
Dec-15-20 08:56AM  
Dec-10-20 09:15AM  
Dec-08-20 09:15AM  
Dec-02-20 09:15AM  
Dec-01-20 08:44AM  
Nov-25-20 09:15AM  
Nov-17-20 09:15AM  
Nov-16-20 11:15PM  
Nov-10-20 04:01PM  
Nov-05-20 03:45PM  
Nov-02-20 09:15AM  
Oct-28-20 07:30AM  
Oct-27-20 09:15AM  
Oct-26-20 09:15AM  
Oct-08-20 09:15AM  
Sep-21-20 09:15AM  
Sep-14-20 09:15AM  
Sep-09-20 09:15AM  
Sep-04-20 09:15AM  
Aug-19-20 08:00AM  
Jul-31-20 02:43PM  
Jul-23-20 08:00AM  
Jul-20-20 08:00AM  
Jun-29-20 11:31AM  
Jun-19-20 08:00AM  
May-22-20 08:00AM  
May-21-20 06:45AM  
May-11-20 08:00AM  
Apr-16-20 08:37AM  
Apr-02-20 10:41AM  
09:00AM  
Mar-24-20 07:00AM  
06:30AM  
Feb-21-20 06:30AM  
Dec-23-19 07:57PM  
Dec-04-19 08:30AM  
Oct-10-19 08:30AM  
Sep-18-19 08:30AM  
Sep-17-19 08:30AM  
Aug-22-19 08:30AM  
Jul-25-19 08:30AM  
Jul-11-19 08:30AM  
Jul-10-19 08:30AM  
Jun-19-19 04:01PM  
Jun-17-19 08:16AM  
Jun-14-19 04:01PM  
07:30AM  
May-22-19 08:30AM  
Apr-29-19 08:00AM  
Mar-26-19 07:34PM  
Mar-06-19 08:30AM  
Feb-25-19 07:40AM  
Feb-06-19 08:30AM  
Dec-13-18 06:00AM  
Nov-26-18 08:30AM  
Nov-07-18 04:45PM  
08:30AM  
Oct-30-18 12:23PM  
Oct-25-18 08:55AM  
Oct-24-18 03:10PM  
12:00PM  
Oct-23-18 04:33PM  
03:55PM  
11:55AM  
10:00AM  
Oct-22-18 05:10PM  
04:25PM  
01:15PM  
11:40AM  
Oct-21-18 10:30PM  
06:00PM  
02:00PM  
11:00AM  
Oct-20-18 01:50PM  
07:00AM  
Oct-19-18 06:26PM  
05:05PM  
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-016, an intravenous treatment that is in Phase I/II clinical trial for COVID-19 patients with respiratory illness; and AP-014, an inhaled treatment that is in Phase I clinical trial for COVID-19 induced respiratory distress. The company is headquartered in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STOKELY DANCFOMar 16Option Exercise0.4340,00017,20068,315Mar 17 06:35 PM
STOKELY DANCFOMar 16Sale1.8340,00073,04828,315Mar 17 06:35 PM
STOKELY DANCFOFeb 12Option Exercise2.5552,500133,87552,500Feb 17 02:51 PM